Sarepta Therapeutics, Inc. (SRPT)
NASDAQ·Healthcare·Biotechnology
$21.12
+0.67%
Mkt Cap $2.17B
Analyst Ratings
Buy
7
Hold
2
Sell
7
Price Target (64 analysts)
$24.50
Range $16.00 – $32.00
Implied Upside
+16.0%
Consensus $24.50 vs current $21.12
NASDAQ·Healthcare·Biotechnology
$21.12
+0.67%
Mkt Cap $2.17B
Buy
7
Hold
2
Sell
7
Price Target (64 analysts)
$24.50
Range $16.00 – $32.00
+16.0%
Consensus $24.50 vs current $21.12